Civic Intelligence

Kansas City Clinical Oncology Program

990 • Fiscal year 2011 • EIN 43-1778437

Jun 01, 2010 to May 31, 2011

Prairie Vlg, KS
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

23rd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2011 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2011

Liabilities / Revenue

23rd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2011 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2011

Net Margin

24th percentile

-8.1%

Higher net margin than 24% of similar nonprofits.

2011 filings • 501(c)3 • $500k-$1M nonprofits • Source year 2011

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2011

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2011

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2011

Assets

$708,708

No earlier filing loaded for comparison.

Net Assets

$708,708

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$953,088

No earlier filing loaded for comparison.

Expenses

$1,030,708

No earlier filing loaded for comparison.

Net Income

-$77,620

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$800K$600K$400K$200K$0Assets 2011: $708,708Liabilities 2011: $0Net Assets 2011: $708,7082011Assets 2012: $734,801Liabilities 2012: $0Net Assets 2012: $734,8012012Assets 2013: $699,434Liabilities 2013: $0Net Assets 2013: $699,4342013Assets 2014: $521,690Liabilities 2014: $0Net Assets 2014: $521,6902014Assets 2015: $470,039Liabilities 2015: $0Net Assets 2015: $470,0392015Assets 2016: $506,788Liabilities 2016: $0Net Assets 2016: $506,7882016Assets 2017: $610,853Liabilities 2017: $0Net Assets 2017: $610,8532017Assets 2018: $513,883Liabilities 2018: $0Net Assets 2018: $513,8832018Assets 2019: $498,865Liabilities 2019: $0Net Assets 2019: $498,8652019Assets 2020: $316,827Liabilities 2020: $0Net Assets 2020: $316,8272020Assets 2021: $133,181Liabilities 2021: $0Net Assets 2021: $133,1812021Assets 2022: $110,414Liabilities 2022: $0Net Assets 2022: $110,4142022Assets 2023: $0Liabilities 2023: $0Net Assets 2023: $02023

Highlighted filing

2011

Assets$708,708
Liabilities$0
Net Assets$708,708

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0-$500KRevenue 2011: $953,088Expenses 2011: $1,030,708Net Income 2011: -$77,6202011Revenue 2012: $834,825Expenses 2012: $808,732Net Income 2012: $26,0932012Expenses 2013: $803,8632013Revenue 2014: $745,974Expenses 2014: $923,718Net Income 2014: -$177,7442014Revenue 2015: $782,617Expenses 2015: $834,268Net Income 2015: -$51,6512015Revenue 2016: $800,213Expenses 2016: $734,561Net Income 2016: $65,6522016Revenue 2017: $893,152Expenses 2017: $789,087Net Income 2017: $104,0652017Revenue 2018: $661,055Expenses 2018: $758,034Net Income 2018: -$96,9792018Revenue 2019: $722,037Expenses 2019: $737,055Net Income 2019: -$15,0182019Revenue 2020: $144,038Expenses 2020: $326,075Net Income 2020: -$182,0372020Revenue 2021: $0Expenses 2021: $183,646Net Income 2021: -$183,6462021Revenue 2022: $0Expenses 2022: $22,767Net Income 2022: -$22,7672022Revenue 2023: $0Expenses 2023: $110,414Net Income 2023: -$110,4142023

Highlighted filing

2011

Revenue$953,088
Expenses$1,030,708
Net Income-$77,620
Filing Detail Status

This 2011 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jun 1, 2010 to May 31, 2011
Mission and Program Overview

Mission

To promote and contribute to the public welfare by advancement of medicine, including, but not limited to promoting research in cancer treatment and prevention.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings